| Literature DB >> 23459708 |
María Carmen Mirón-García1, Ana Isabel Garrido-Godino, Varinia García-Molinero, Francisco Hernández-Torres, Susana Rodríguez-Navarro, Francisco Navarro.
Abstract
The unconventional prefoldin URI/RMP, in humans, and its orthologue in yeast, Bud27, have been proposed to participate in the biogenesis of the RNA polymerases. However, this role of Bud27 has not been confirmed and is poorly elucidated. Our data help clarify the mechanisms governing biogenesis of the three eukaryotic RNA pols. We show evidence that Bud27 is the first example of a protein that participates in the biogenesis of the three eukaryotic RNA polymerases and the first example of a protein modulating their assembly instead of their nuclear transport. In addition we demonstrate that the role of Bud27 in RNA pols biogenesis depends on Rpb5. In fact, lack of BUD27 affects growth and leads to a substantial accumulation of the three RNA polymerases in the cytoplasm, defects offset by the overexpression of RPB5. Supporting this, our data demonstrate that the lack of Bud27 affects the correct assembly of Rpb5 and Rpb6 to the three RNA polymerases, suggesting that this process occurs in the cytoplasm and is a required step prior to nuclear import. Also, our data support the view that Rpb5 and Rpb6 assemble somewhat later than the rest of the complexes. Furthermore, Bud27 Rpb5-binding but not PFD-binding domain is necessary for RNA polymerases biogenesis. In agreement, we also demonstrate genetic interactions between BUD27, RPB5, and RPB6. Bud27 shuttles between the nucleus and the cytoplasm in an Xpo1-independent manner, and also independently of microtubule polarization and possibly independently of its association with the RNA pols. Our data also suggest that the role of Bud27 in RNA pols biogenesis is independent of the chaperone prefoldin (PFD) complex and of Iwr1. Finally, the role of URI seems to be conserved in humans, suggesting conserved mechanisms in RNA pols biogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23459708 PMCID: PMC3573130 DOI: 10.1371/journal.pgen.1003297
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Figure 1Bud27 physically interacts with the three RNA polymerases.
A) Growth of BUD27-TAP, Wild-type and a Δbud27 cells inYPD at the indicated temperatures. B) Summary of the proteins interacting with Bud27 in a TAP purification analysis. C) Western blot of protein co-purified with Bud27-TAP (3), Rpb3-TAP (2), and non- tagged wild-type strains (1). anti-HA, anti-Myc, anti-Rpb1 (8WG16), and anti-PAP antibodies were used. No tag: wild-type strain BY4741; Rpb3-TAP: Rpb3-TAP, Rpa190-HA (RNA pol I) and Rpc25-Myc (RNA pol III) strain; Bud27-TAP: Bud27-TAP, Rpa190-HA (RNA pol I) and Rpc25-Myc (RNA pol III) strain.
Figure 2Bud27 shuttles between nucleus and cytoplasm.
Live cell imaging of Bud27-Gfp (centromeric plasmid pCM189) in Δbud27 mutant cells at 30°C (A) and Xpo-1 mutant cells for 1 h at 37°C (B). C) Live cell imaging of Bud27ΔNES-GFP in Δbud27 mutant cells at 30°C, showing nuclear localization. D) Rpb8-ECFP (C-terminal ECFP tagged Rpb8) and Bud27ΔNES-GFP in wild-type or Δbud27 mutant cells treated with benomyl (60 µg/ml) at 30°C.
Figure 3Lack of Bud27 led to RNA pol I, II, and III cytoplasmic accumulation.
A) Immunocytochemistry experiments using antibodies against Rpa190-HA (anti-HA), Rpb1 (8WG16), and Rpc160-Myc (anti-Myc) in wild-type and Δbud27 mutant cells with tagged Rpa190-HA (RNA pol I) and Rpc160-Myc (RNA pol III), at 30°C. B) Live cell imaging of Rpb8-ECFP in wild-type and Δbud27 mutant cells, at 30°C. C) Western blot of chromatin fractions from wild-type and Δbud27 mutant cells harbouring an empty vector (pCM) or a vector overexpressing BUD27 (pCM-BUD27-TAP). Tubulin and Nop1 were used as controls of non-chromatin and chromatin fractions, respectively. D) Rpb1 immunolocalisation analysis (8WG16) in human pulmonary fibroblast under silencing of URI. As a control, cells without siRNA heteroduplex.
Figure 4Lack of Bud27 affects assembly of RNA pol I, II, and III.
A) RNA pol II was immunoprecipitated with anti-Rpb1 antibodies (8WG16) from a strain containing Rpb2-TAP, Rpb3-HA and Rpb4-Myc. RNA pol II subunits were analysed with Anti-HA, anti-Rpb1 (8WG16), anti-Myc, anti-PAP, anti-Rpb5 and anti-Rpb6 antibodies. B) Western blot of Rpb1 co-purified with RPB2-TAP. Anti-Rpb1 (8WG16) and anti-PAP antibodies were used. C) RNA pol I, II and III were immunoprecipitated with anti-HA, anti-Rpb1 (8WG16) and anti-Myc antibodies from a wild-type and a Δbud27 mutant strains containing Rpa190-HA (RNA pol I) and Rpc160-Myc (RNA pol III), transformed with a plasmid overexpressing RPB5 (pFL-RPB5), or with an empty vector (pFL). Rpa190-HA, Rpb1, Rpc160-Myc, Rpb5, and Rpb6 were analysed by Western blot with the antibodies indicated above.
Figure 5Δbud27 mutant phenotypes are corrected by overexpression of different BUD27 constructions and RPB5.
A) Growth of wild-type and Δbud27 mutant strains transformed with vectors overexpressing RPB5, at different temperatures or in the presence of rapamycin. pCM and pFL correspond to the control empty vectors. B) Live cell imaging of Rpb8-ECFP in wild-type and Δbud27 mutant cells at 30°C, containing empty vector (pFL) or overexpressing RPB5 (pFL-RPB5).
Figure 6PFD, Rpb5-binding domains, or both are dispensable for RNA pol I, II, and III nuclear localization.
Live cell imaging of Rpb8-ECFP and Rpb1-GFP in Δbud27 mutant cells at 30°C, containing vectors overexpressing whole BUD27 or BUD27 deleted for PFD, Rpb5-binding domains or both.
Figure 7RNA pol I, II, and III nuclear localization is independent of the chaperone prefoldin (PFD) complex.
Live cell imaging of Rpb8-ECFP and Rpb1-GFP in Δbud27, Δgim6 (Δpfd1), Δgim4 (Δpfd2), and Δyke2 (Δpfd6) mutant cells containing C-terminal ECFP tagged Rpb8 and C-terminal GFP tagged Rpb1, at 30°C.
Figure 8Iwr1 nuclear localization is independent of Bud27.
Live cell imaging of Iwr1-Gfp deleted for its NES domain in wild-type and Δbud27 cells at 30°C.
S. cerevisiae strains.
| Strain | Genotype | Origin |
| BY4741 |
| Euroscarf |
| BY4742 |
| Euroscarf |
| Y01246 |
| Euroscarf |
| Y00243 |
| Euroscarf |
| Y04149 |
| Euroscarf |
| Y05642 |
| Euroscarf |
| ATCC201388 ( |
| Invitrogen |
| YSC1178 ( |
| Open Biosystems |
| YSC1178 ( |
| Open Biosystems |
| W303-1A |
|
|
| W303-1B |
|
|
| YPH500 |
|
|
| MW3522 |
|
|
| XPO1 |
|
|
| xpo1-1 |
|
|
| YVV50-4c |
|
|
| D473-4A |
| Gift from P. Thuriaux |
| LMY3.1 |
| Gift from S. Chávez |
| MW3608 |
| Gift from M. Werner |
| SL876a |
| Gift from P. Thuriaux |
| YCZ106 |
| Gift from P. Thuriaux |
| D495-1c |
| This workYFN56×YCZ106 |
| D610-11A |
| This workY05642×D473-4A |
| YFN56 |
| This workSL876a×MW3522 |
| YFN105 |
| This workBY4741×D610-11A |
| YFN106 |
| This workBY4741×D610-11A |
| YFN223 |
| This workD495-1c×MW3608 |
| YFN229 |
| This workD495-1c×W303-1A |
| YFN233 |
| This workYFN223×YFN105 |
| YFN255 |
| This workYFN229×YSC1178 ( |
| YFN289 |
| This workYSC1178( |
| YFN308 |
| This workYFN289×LMY3.1 |
| YFN323 |
| This workYFN106×YVV50-4c |
| YFN329 |
| This workYFN323×YFN308 |
| YFN331 |
| This workYFN323×YFN308 |
| YFN334 |
| This work |
| YFN335 |
| This work |
| YFN348 |
| This work |
| YFN349 |
| This work |
| YFN350 |
| This work |
| FY86 |
| Gift from F. Estruch |
| YFN416 |
| This work |
| YFN417 |
| This work |
| YFN418 |
| This work |
| YFN419 |
| This work |
| YFN420 |
| This work |
Plasmids.
| Name | Yeast markers | Origin |
| pCM189 | ORI (CEN) |
|
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pCM189- | ORI (CEN) | This work |
| pFL44L | ORI (2 µm) |
|
| pFL44L- | ORI (2 µm) |
|
| pCM189- | ORI (CEN) | Gómez-Navarro et al, submitted |
| pKT210 |
|
Primers.
| Name | Sequence |
| Rpb8ECFP-501 |
|
| Rpb8ECFP-301 |
|
| Rpb1-508 |
|
| Rpb1-310 |
|
| hsURI1_02 |
|
| hsURI1_02_as |
|
| hsURI1E9-f01 |
|
| hsURI1E10-r01 |
|
| PPIA 501 |
|
| PPIA 301 |
|